Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dafni Birmpili"'
Autor:
Dafni Birmpili, Imane Charmarké-Askar, Caroline Spenlé, Stéphanie Riché, Lucas Dinh Pham-Van, Thomas Kuntzel, Thanos Xhurxhi, Aurélien Riou, Dominique Bonnet, Dominique Bagnard
Publikováno v:
Neurobiology of Disease, Vol 198, Iss , Pp 106552- (2024)
Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease leading to demyelination and axonal loss. Current treatments are immunomodulatory or immunosuppressive drugs acting on the inflammatory component. However, these treatments do not
Externí odkaz:
https://doaj.org/article/d6a8bcf65928493eb6c8d4e372fd28a1
Autor:
Thomas Kuntzel, Caroline Spenlé, Lucas D. Pham-Van, Dafni Birmpili, Aurélien Riou, Aurore Loeuillet, Imane Charmarke-Askar, Dominique Bagnard
Publikováno v:
Cells, Vol 12, Iss 10, p 1361 (2023)
Interleukin 10 (IL-10) exerts anti-inflammatory and immune regulatory roles through its fixation to the IL-10 receptor (IL-10R). The two subunits (IL-10Rα and IL-10Rβ) organise themselves to form a hetero-tetramer to induce the activation of the tr
Externí odkaz:
https://doaj.org/article/6e26df93d2f84b2c9ddfb4c4459a9be8
Autor:
Dafni Birmpili, Imane Charmarke Askar, Lucas Dinh Pham-Van, Thomas Kuntzel, Caroline Spenlé, Aurélien Riou, Dominique Bagnard
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14000 (2022)
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system associated with chronic inflammation, demyelination, and axonal damage. MS is a highly heterogeneous disease that leads to discrepancies regarding the clinical appe
Externí odkaz:
https://doaj.org/article/ed634d3416b64bbb9f393eac9494d116
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11532 (2022)
Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system which is characterized by demyelinating lesions and axonal damage. MS is a complex disease characterized by important pathophysiological heterogeneity affect
Externí odkaz:
https://doaj.org/article/5308961967f14d7ab54124ac89880a24
Autor:
Fabien Binamé, Lucas D Pham‐Van, Caroline Spenlé, Valérie Jolivel, Dafni Birmpili, Lionel A Meyer, Laurent Jacob, Laurence Meyer, Ayikoé G Mensah‐Nyagan, Chrystelle Po, Michaël Van der Heyden, Guy Roussel, Dominique Bagnard
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 11, Pp n/a-n/a (2019)
Abstract Current treatments in multiple sclerosis (MS) are modulating the inflammatory component of the disease, but no drugs are currently available to repair lesions. Our study identifies in MS patients the overexpression of Plexin‐A1, the signal
Externí odkaz:
https://doaj.org/article/9c93a265f0e349ccb476894277fab549